Patterns of Cerebrospinal Fluid Alzheimer’s Dementia Biomarkers in People Living with HIV: Cross-Sectional Study on Associated Factors According to Viral Control, Neurological Confounders and Neurocognition

CSF markers of AD-related pathology relate specifically to memory impairment in older people with HIV: a pilot study

(2022) Judith D. Lobo et al.   JOURNAL OF NEUROVIROLOGY

Alzheimer’s-Like Pathology at the Crossroads of HIV-Associated Neurological Disorders

(2021) Divya T. Chemparthy et al.   Vaccines

Comparison of dementia incidence and prevalence between individuals with and without HIV infection in primary care from 2000 to 2016

(2021) Jennifer O. Lam et al.   AIDS

Low cerebrospinal fluid Amyloid-βeta 1–42 in patients with tuberculous meningitis

(2021) Giacomo Stroffolini et al.   BMC Neurology

Beta amyloid levels in CSF of HIV-infected people vary by exposure to antiretroviral therapy

(2020) Jerel Adam Fields et al.   AIDS

HIV-1 Tat-mediated astrocytic amyloidosis involves the HIF-1α/lncRNA BACE1-AS axis

(2020) Susmita Sil et al.   PLOS BIOLOGY

Brain amyloid in virally suppressed HIV-associated neurocognitive disorder

(2020) Gemma C. Howdle et al.   Neurology-Neuroimmunology & Neuroinflammation

HIV and risk of dementia in older veterans

(2020) Kirsten Bobrow et al.   AIDS

Chronic inflammation mediates brain injury in HIV infection: relevance for cure strategies

(2020) Justin C. McArthur et al.   CURRENT OPINION IN NEUROLOGY

Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016

(2020) Julia L. Marcus et al.   JAMA Network Open

Comparison of dementia risk after age 50 between individuals with and without HIV infection

(2020) Jennifer O. Lam et al.   AIDS

Mechanisms and therapeutic potential of interactions between human amyloids and viruses

(2020) Emiel Michiels et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Cerebrospinal fluid biomarkers in patients with central nervous system infections: a retrospective study

(2019) Alessandro Di Stefano et al.   CNS SPECTRUMS

Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers

(2019) Jinny Claire Lee et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Linked CSF reduction of phosphorylated tau and IL-8 in HIV associated neurocognitive disorder

(2019) Tugba Ozturk et al.   Scientific Reports

Association of antiretroviral therapy with brain aging changes among HIV-infected adults

(2018) Virawudh Soontornniyomkij et al.   AIDS

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

(2018) Clifford R. Jack et al.   Alzheimers & Dementia

HIV-1 increases extracellular amyloid-beta levels through neprilysin regulation in primary cultures of human astrocytes

(2018) Marta Martínez-Bonet et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Alzheimer’s disease neuropathology may not predict functional impairment in HIV: a report of two individuals

(2018) Susan Morgello et al.   JOURNAL OF NEUROVIROLOGY

HIV Neuroinfection and Alzheimer’s Disease: Similarities and Potential Links?

(2018) Geoffrey Canet et al.   Frontiers in Cellular Neuroscience

Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities

(2018) Mattia Trunfio et al.   AIDS

Tau Positron Emission Tomography Binding Is Not Elevated in HIV-Infected Individuals

(2018) Sarah A Cooley et al.   JOURNAL OF INFECTIOUS DISEASES

The Possibility of an Infectious Etiology of Alzheimer Disease

(2018) Ghulam M. Ashraf et al.   MOLECULAR NEUROBIOLOGY

Somatic APP gene recombination in Alzheimer’s disease and normal neurons

(2018) Ming-Hsiang Lee et al.   NATURE

Biomarkers of neuronal injury and amyloid metabolism in the cerebrospinal fluid of patients infected with HIV-1 subtypes B and C

(2017) Sérgio Monteiro de Almeida et al.   JOURNAL OF NEUROVIROLOGY

HIV-1 counteracts an innate restriction by amyloid precursor protein resulting in neurodegeneration

(2017) Qingqing Chai et al.   Nature Communications

Health-adjusted life expectancy in HIV-positive and HIV-negative men and women in British Columbia, Canada: a population-based observational cohort study

(2017) Robert S Hogg et al.   Lancet HIV

APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals – a cross-sectional observational study

(2015) Lucette A Cysique et al.   BMC Neurology

Future challenges for clinical care of an ageing population infected with HIV: a modelling study

(2015) Mikaela Smit et al.   LANCET INFECTIOUS DISEASES

The cerebrospinal fluid biomarker profile in an HIV-infected subject with Alzheimer’s disease

(2015) Signar Mäkitalo et al.   AIDS Research and Therapy

Cerebrospinal Fluid (CSF) Neuronal Biomarkers across the Spectrum of HIV Infection: Hierarchy of Injury and Detection

(2014) Julia Peterson et al.   PLoS One

Evolving Character of Chronic Central Nervous System HIV Infection

(2014) Serena Spudich et al.   SEMINARS IN NEUROLOGY

HIV-1 Tat Interacts with and Regulates the Localization and Processing of Amyloid Precursor Protein

(2013) Jiyoung Kim et al.   PLoS One

11C-PiB Imaging of Human Immunodeficiency Virus–Associated Neurocognitive Disorder

(2012) Beau M. Ances   ARCHIVES OF NEUROLOGY

Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections

(2012) Jan Jessen Krut et al.   JOURNAL OF NEUROLOGY

The Effect of HIV Protease Inhibitors on Amyloid-β Peptide Degradation and Synthesis in Human Cells and Alzheimer’s Disease Animal Model

(2011) Xiqian Lan et al.   Journal of Neuroimmune Pharmacology

Cognitively unimpaired HIV-positive subjects do not have increased 11C-PiB: A case-control study

(2010) B. M. Ances et al.   NEUROLOGY

Amyloid and tau cerebrospinal fluid biomarkers in HIV infection

(2009) Magnus Gisslén et al.   BMC Neurology